Bee Venom Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis

다국어 초록 (Multilingual Abstract)

a

국문 초록 (Abstract)

목적 : 이 연구는 봉독이 세포자멸사 관련 단백질의 발현 조절을 통하여 세포자멸사를 유도하고 전립선 암세포주인 DU-145 세포의 성장을 억제하는지를 확인하고 해당 기전을 살펴보고자 하였다.
방법 : 봉독을 처리한 후 DU-145의 세포자멸사를 관찰하기 위해 TUNEL staining assay를 시행하였으며, 세포자멸사 조절단백질의 변동 관찰에는 western blot analysis를 시행하였다.
결과 : DU-145 세포에 봉독을 처리한 후, 세포자멸사의 유발, 세포자멸사 관련 단백질의 발현에 미치는 영향을 관찰하여 다음과 같은 결과를 얻었다.
1. DU-145 세포에서 봉독을 처리한 후 세포자멸사가 유도되어 세포성장이 억제되었다.
2. 세포자멸사 관련 단백질 중 분리된 pro-apoptotic proteins인 PARP, caspase-3, caspase-9은 유의한 증가를 나타내었다.
3. 세포자멸사 관련 단백질 중 분리된 anti-apoptotic proteins인 Bcl-2, p-AKT, XIAP, cIAP2는 유의한 감소를, MMP2, MMP13은 유의한 증가를 나타내었다.
결론 : 이상의 결과는 봉독이 인간 전립선 암세포주인 DU-145의 세포자멸사를 유발함으로써 전립선암세포 증식억제 효과가 있음을 입증한 것으로 전립선암의 예방과 치료에 대한 효과적인 치료제 개발에 도움이 될 것으로 기대된다.

참고문헌 (Reference)

1 Nesterov A, "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells" 21 : 1135-1140, 2002

2 YB Kwon, "The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats" 71 : 191-204, 2002

3 LaCasse EC, "The inhibitors of apoptosis (IAPs) and their emerging role in cancer" 17 : 3247-3259, 1998

4 Wyllie AH, "The genetic regulation of apoptosis. Curr" 5 (5): 97-104, 1995

5 Cory S, "The Bcl2 family: regulators of the cellular life-or-death switch" 2 : 647-656, 2002

6 Zu K, "Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells" 63 : 6988-6995, 2003

7 Singh AV, "Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo" 25 : 83-90, 2004

8 Simon HU, "Role of reactive oxygen species (ROS) in apoptosis induction" 5 : 415-418, 2000

9 Fini ME, "Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases" Academic Press 299-356, 1998

10 Cardone MH, "Regulation of cell death protease caspase-9 by phosphorylation" 282 : 1318-1321, 1998

11 Gurumurthy S, "Regulation of apoptosis in prostate cancer" 20 : 22543-, 2001

12 K Abdelmohsen, "Phosphorylation of HuR by Chk2 regulates SIRT1 expression" CELL PRESS 25 (25): 543-557, 2007

13 Schally AV, "Peptide analogs in the therapy of prostate cancer" 45 : 158-166, 2000

14 Cai RZ, "New pseudononapeptide bombesin antagonist with C-terminal LeuW (CH2N)Tac-NH2 showing high binding affinity to bombesin/GRP receptors on CFPAC-1 human pancreatic cancer cell line" 6 : 1165-1172, 1995

15 Kantoff PW, "New agents in the therapy of hormone-refractory patients with prostate cancer" 22 (22): 324-, 1995

16 Sedlak TW, "Multiple Bcl2 family members demonstrate selective dimerization with Bax" 92 : 7834-7838, 1995

17 Green DR, "Mitochondria and Apoptosis" 281 : 1309-1312, 1998

18 Hye Ji Park, "Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death" 한국독성학회 22 (22): 31-37, 2006

19 Visse R, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry" 92 : 827-839, 2003

20 Benimetskaya L, "Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer Bee Venom Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis 119 cells" 60 : 129630-129637, 2001

21 Nachshon-Kedmi M, "Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway" 91 : 1358-1363, 2004

22 Dasmahapatra GP, "In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines" 10 : 5242-5252, 2004

23 Deveraux QL, "IAP family proteins suppressors of apoptosis" 13 : 239-252, 1999

24 Y Akao, "High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecininduced up-regulation" 342 : 1284-1290, 2006

25 K Mizutani, "Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells" 28 : 209-215, 2006

26 Guseva NV, "Death receptor-induced cell death in prostate cancer" 91 : 7099-, 2004

27 Y Akao, "Ceramide accumulation is independent of camptothecin- induced apoptosis in prostate cancer LNCaP cells" 294 : 363-370, 2002

28 Thornberry NA, "Caspases : enemies within" 281 : 1312-1316, 1998

29 Jemal A, "Cancer Statistics" 55 : 10-30, 2005

30 오현준, "Bee Venom Inhibits PC-3 Cell Proliferation Through Iinduction of Apoptosis Via Inactivation of NF-κB" 대한침구의학회 27 (27): 1-13, 2010

31 Lee Hong-sun, "Bee Venom Inhibits LNCaP Cell Proliferation Through Induction of Apoptosis Via Inactivation of NF-κB" 대한침구의학회 25 (25): 59-74, 2008

32 Bettaieb A, "Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells" 3 : 307-318, 2003

33 Reed JC, "Apoptosis-based therapies" 1 : 11121-, 2002

34 Lowe SW, "Apoptosis in cancer" 21 : 48595-, 2000

35 Pugazhenthi S, "Akt/ protein kinase B upregulates Bcl2 expression through cAMP-response element-binding protein" 275 : 10761-10766, 2000

36 Darmon AJ, "Activation of the apoptotic proteaseCPP32 by cytotoxic T cell derived granzyme B" 377 : 446-448, 1995

37 Sun M, "AKT1/PKB alpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells" 159 (159): 431-437, 2001

38 Keitaro K, "A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells" 373 : 423-428, 2008

39 Holle L, "A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo" 22 : 93-98, 2003